INS and atherosclerosis: The strengths of our study include the comprehensive assessment of three CAMs, the robust evaluation of specific patients’ characteristics, and the comprehensive assessment of a full lipid profile, subclinical atherosclerosis, and insulin resistance indices including beta-cell function through C-peptide analysis.